Abstract
Most urticaria subtypes have a profound impact on patients’ quality of life and performance. Effective treatment is thus required in all cases where the avoidance of eliciting factors and the elimination of underlying causes is not feasible. In nearly all subtypes histamine released by mast cells plays apredominant role. For symptomatic relief second generation nonsedating histamine H1 receptor (H1R)-antihistamines are, therefore, the first choice. However, double-blind controlled studies have shown that dosages required to achieve complete protection from urticaria symptoms may exceed those recommended for other diseases, e.g., allergic rhinitis. Therefore, the current guidelines suggest increasing the dosage up to fourfold, whereas alternative treatments should be reserved as add-on therapy for unresponsive patients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Poon E, Seed PT, Greaves MW et al. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999; 140:667–671.
Sheldon JM, Mathews KP, Lovell RG. The vexing urticaria problem. Present concepts of etiology and management. J Allergy 1954; 25:525–560.
Champion RH, Roberts SOB, Carpenter RG et al. Urticaria and angioedema: a review of 554 patients. Br J Derm 1969; 81:588–597.
Swinny B. The atopic factor in urticaria. South Med J 1941; 34:855–858.
Iffländer J. Akute Urtikaria—Ursachen, Verlauf und Therapie. Berlin, Humboldt University Diss. (Med Doct) 1999.
Zuberbier T, Iffländer J, Semmler C et al. Acute urticaria—clinical aspects and therapeutical responsiveness. Acta Derm Venereol (Stockh) 1996; 76:295–297.
Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol 1981; 104:369–381.
Zuberbier T, Chantraine-Hess S, Hartmann K et al. Pseudoallergen-free diet in the treatment of chronic urticaria—a prospective study. Acta Derm Venereol (Stockh) 1995; 75:484–487.
Pigatto PD, Valsecchi RH. Chronic urticaria: a mystery. Allergy 2000; 55:306–330.
Zuberbier T, Pfrommer C, Specht K et al. Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. J Allergy Clin Immunol 2002; 109:348–349.
Hide M, Francis DM, Grattan CEH et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328:1599–1604.
Fiebiger E, Hammerschmid F, Stingl G et al. Anti-FcεRI-α autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998; 101:243–251.
Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001; 107:1056–1062.
Zuberbier T, Fiebiger E, Maurer D et al. Anti-FcεRIα serum autoantibodies in different subtypes of urticaria. Allergy 2000; 55:951–954.
Stadler BM, Pachlopnik J, Vogel M et al. Conditional autoantibodies in urticaria patients: a unifying hypothesis. J Investig Dermatol Symp Proc 2001; 6:150–152.
Horn MP, Pachlopnik JM, Vogel M et al. Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies? FASEB J 2001; 15:2268–2274.
Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84:66–71.
Wedi B, Kapp A. Helicobacter pylori infection and skin diseases. J Physiol Pharmacol 1999; 50:753–776.
Gaig P, Garcia-Ortega P, Enrique E et al. Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study. Allergol Immunopathol (Madr) 2002; 30:255–258.
Schnyder B, Helbing A, Pichler WJ. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol 1999; 119:60–63.
Wedi B, Kapp A. Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol 2002; 3:273–282.
Bruno G, Andreozzi P, Graf U. Exercise-induced urticaria—angioedema syndrome: A role in gastroesophageal reflux. In: Vena GA, Puddu P, eds. Proceedings of the international symposium on urticaria. Bari: Publ Scientif 1998; 85–89.
Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM, Grattan CE, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B. EAACI/GA2LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427–1443.
Zuberbier T, Münzberger Ch, Haustein U et al. Double-blind crossover study of high dose cetirizine in cholinergic urticaria. Dermatology 1996; 193:324–327.
Kontou-Fili K, Maniakatou G, Demaka P et al. Therapeutic effect of cetirizine 2HCl in delayed pressure urticaria. Health Sci Rev 1989; 3:23–25.
Siebenhaar F, Degener F, Zuberbier T et al. High-dose Desloratadine Decreases Wheal Volume and Improves Cold Provocation Thresholds as Compared with Standard Dose Treatment in Patients with Acquired Cold Urticaria: A Randomized, Placebo-Controlled, Crossover Study. J Allergy Clin Immunol 2009 in press.
Asero R. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatology; 2007; 32:34–38.
Ridout SM, Tariq SM. Cetirizine overdose in a young child. J Allergy Clin Immunol 1997; 99:860–861.
Weber-Schoendorfer C, Schaefer C. The safety of cetirizine during pregnancy. A prospective observational cohort study. Reprod Toxicol 2008; 26:19–23.
Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B, Maurer M. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417–1426.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Landes Bioscience and Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Zuberbier, T., Maurer, M. (2010). Antihistamines in the Treatment of Urticaria. In: Thurmond, R.L. (eds) Histamine in Inflammation. Advances in Experimental Medicine and Biology, vol 709. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8056-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8056-4_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-8055-7
Online ISBN: 978-1-4419-8056-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)